Evidence map›Paper›PMID 31078691›Full record

ArticleBrain, behavior, and immunity2019

Glucocorticoids mediate stress induction of the alarmin HMGB1 and reduction of the microglia checkpoint receptor CD200R1 in limbic brain structures.

Matthew G Frank, Jessica L Annis, Linda R Watkins, Steven F Maier

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Matthew G FrankDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80301, USA; Center for Neuroscience, University of Colorado Boulder, Boulder, CO 80301, USA. Electronic address: matt.frank@colorado.edu.
Jessica L AnnisDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA.
Linda R WatkinsDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80301, USA; Center for Neuroscience, University of Colorado Boulder, Boulder, CO 80301, USA.
Steven F MaierDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80301, USA; Center for Neuroscience, University of Colorado Boulder, Boulder, CO 80301, USA.
University of Colorado Boulder · USUniversity of Virginia · US

Funding

Stress-induced neuroinflammatory priming: Glucocorticoids, inflammasomes, alarminsR01MH108523 · NIMH · UNIVERSITY OF COLORADO · PI MAIER, STEVEN F · 2016 to 2020
$2.1M
NIMH NIH HHS R01 MH108523
6 · The paper itself

Abstract

Exposure to stressors primes neuroinflammatory responses to subsequent immune challenges and stress-induced glucocorticoids (GCs) play a mediating role in this phenomenon of neuroinflammatory priming. Recent evidence also suggests that the alarmin high-mobility group box-1 (HMGB1) and the microglial checkpoint receptor CD200R1 serve as proximal mechanisms of stress-induced neuroinflammatory priming. However, it is unclear whether stress-induced GCs play a causal role in these proximal mechanisms of neuroinflammatory priming; this forms the focus of the present investigation. Here, we found that exposure to a severe acute stressor (inescapable tailshock) induced HMGB1 and reduced CD200R1 expression in limbic brain regions and pharmacological blockade of GC signaling (RU486) mitigated these effects of stress. To confirm these effects of RU486, adrenalectomy (ADX) with basal corticosterone (CORT) replacement was used to block the stress-induced increase in GCs as well as effects on HMGB1 and CD200R1. As with RU486, ADX mitigated the effects of stress on HMGB1 and CD200R1. Subsequently, exogenous CORT was administered to determine whether GCs are sufficient to recapitulate the effects of stress. Indeed, exogenous CORT induced expression of HMGB1 and reduced expression of CD200R1. In addition, exposure of primary microglia to CORT also recapitulated the effects of stress on CD200R1 suggesting that CORT acts directly on microglia to reduce expression of CD200R1. Taken together, these findings suggest that GCs mediate the effects of stress on these proximal mechanisms of neuroinflammatory priming.

Indexed as

AnimalsBrainCorticosteroneGlucocorticoidsHippocampusHMGB1 ProteinInflammationLimbic SystemLipopolysaccharidesMaleMicrogliaMifepristoneNeuroimmunomodulationRatsRats, Sprague-DawleyReceptors, ImmunologicCd200 protein, ratCorticosteroneGlucocorticoidsHbp1 protein, ratHMGB1 ProteinLipopolysaccharidesMifepristoneReceptors, ImmunologicAlarminCD200R1GlucocorticoidHMGB1NeuroinflammationPrimingStress

Identifiers

PMID31078691
PMCPMC6662571
OpenAlexW2944284771

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.